Gvoke Kit Injection, Solution
Product Images NDC 72065-140

Product Visual Gallery

This gallery contains 67 technical images submitted to the FDA as part of the official labeling for Gvoke Kit (NDC 72065-140). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xeris Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Its Molecular Formula Is C153h225n43o49s With The Following Structure: (Gvoke 1)

Chemical structure diagram showing a peptide sequence labeled with amino acid abbreviations and their corresponding positions 1 to 29, ending with a carboxyl group (-COOH). The sequence includes common amino acids such as His, Ser, Gln, Asp, and Phe arranged in a linear order.*

FDA Label Image

Figure 1 (Gvoke 2)

A line graph depicting mean plasma glucose levels (mg/dL) over time (minutes) after administration of 1 mg Gvoke in 154 subjects. The graph shows increasing glucose levels from baseline through 90 minutes, with error bars indicating variability at each time point.*

FDA Label Image

Figure 2 (Gvoke 3)

A line graph depicting mean plasma glucose levels (mg/dL) over time (minutes) for three pediatric age groups treated with Gvoke PFS at different doses. The groups include ages 2 to under 6 years (0.5 mg), ages 6 to under 12 years (0.5 mg), and ages 12 to under 18 years (1 mg). The graph shows glucose increases from baseline to about 90 minutes, with error bars indicating variability.*

FDA Label Image

Figure 3 (Gvoke 4)

A line chart displaying mean glucagon levels (pg/mL) over time in minutes after injection of 1 mg GVOKE in a sample size of 78. The graph shows a rapid increase to a peak at around 30-40 minutes followed by a gradual decline until 240 minutes post-injection.*

FDA Label Image

Figure 4 (Gvoke 5)

A line graph showing mean glucagon levels (pg/mL) over time (minutes) from injection. Three groups are compared: G1 (ages 2 to under 6 years, 0.5 mg dose), G2 (ages 6 to under 12 years, 0.5 mg dose), and G3 (ages 12 to under 18 years, 1 mg dose). Mean glucagon peaks around 30-40 minutes post-injection for all groups, followed by a gradual decline through 180 minutes.*

FDA Label Image

Ai Pouch 1 mg (Gvoke 6)

Instructional diagram for Gvoke HypoPen glucagon injection 1 mg per 0.2 mL auto-injector by Xeris Pharmaceuticals. It outlines three steps: Prepare (tear open pouch, remove red cap, choose injection site on lower abdomen, outer thigh, or outer upper arm), Inject (push down on skin and hold for 5 seconds until window turns red), and Assist (turn patient on side and call emergency help). The diagram includes images of the pen's red cap and needle end.*

FDA Label Image

Ai Pouch 0.5 mg (Gvoke 7)

Label for Gvoke HypoPen glucagon injection 0.5 mg per 0.1 mL pre-filled syringe by Xeris Pharmaceuticals. The label includes step-by-step visual instructions for use: preparing by tearing the pouch and removing the red cap, choosing injection sites on the lower abdomen, outer thigh, or outer upper arm, injecting by holding down for 5 seconds until a window turns red, and assisting the patient by turning them on their side and calling emergency medical help. The label states it contains 1 single-dose auto-injector and highlights disposal instructions for the used pen.*

FDA Label Image

Ai Image (Gvoke 8)

An illustrated diagram of the Gvoke PFS 0.5 mg Pre-filled Syringe showing its parts labeled: a red cap, needle end, yellow needle guard, and medication viewing window. The syringe body is white and cylindrical with a viewing window to see the medication inside.*

FDA Label Image

Ifua-sideb-f1 (Gvoke 9)

An instructional illustration depicting how to remove a Gvoke PFS pre-filled syringe from its packaging. One panel shows hands peeling a protective strip from a sealed container, and the other panel shows a hand holding the syringe with a finger pointing at the syringe window, indicating proper handling and preparation steps.*

FDA Label Image

Ifua-sideb-f2 (Gvoke 10)

An instructional illustration showing a hand holding a Gvoke PFS pre-filled syringe with its expiration date area magnified for clarity. The expiration date is indicated by placeholder text 'EXP: YYYY MM', emphasizing where to check the expiration on the syringe label.*

FDA Label Image

Ifua-sideb-f3 (Gvoke 11)

An instructional diagram showing a close-up view of a hand holding a pre-filled syringe with a red cap. The focus is on an indicator window on the syringe barrel, with an eye symbol connected to it, suggesting the user should check the indicator before use.*

FDA Label Image

Ifua-sideb-f4 (Gvoke 12)

An instructional diagram showing a hand pulling off the red cap from a pre-filled syringe. A black arrow points upward from the cap to the syringe needle. The text below reads 'Pull Off Red Cap.' This likely demonstrates the first step in preparing the Gvoke PFS 0.5 mg Pre-filled Syringe for use.*

FDA Label Image

Ifua-sideb-f5 (Gvoke 13)

An instructional illustration showing preferred injection sites for Gvoke PFS 0.5 mg Pre-filled Syringe on a human body. The front view highlights areas on the abdomen and thighs, and the back view indicates spots on the upper outer arms. Blue shaded regions mark the recommended injection zones.*

FDA Label Image

Ifua-sideb-f6 (Gvoke 14)

An instructional illustration showing a person with a yellow shirt and blue shorts. Arrows indicate lifting the shirt to expose the upper arm and the shorts to expose the thigh, demonstrating appropriate skin exposure at injection sites for medication administration.*

FDA Label Image

Ifua-sideb-f7 (Gvoke 15)

An instructional illustration showing how to use a pre-filled syringe. It depicts a hand pushing and holding the syringe down until a 'click' sound is heard, followed by holding it down for 5 seconds, with a stopwatch indicating the duration.*

FDA Label Image

Ifua-sideb-f8 (Gvoke 16)

Instructional illustration showing how to visually check the liquid medicine in the Gvoke PFS 0.5 mg pre-filled syringe. The image focuses on viewing the syringe's red liquid medicine window properly before administration.*

FDA Label Image

Ifua-sideb-f9 (Gvoke 17)

Instructional illustration showing the Gvoke PFS pre-filled syringe being lifted away from the skin after injection, with a yellow needle guard locking over the needle for safety.*

FDA Label Image

Ifua-sideb-f10 (Gvoke 18)

Instructional diagram showing a person rolling from a lying flat position onto their side, demonstrating a step in a procedure or first aid technique labeled 'Roll Onto Side.'*

FDA Label Image

Ifua-sideb-f11 (Gvoke 19)

An instructional illustration showing proper disposal of the Gvoke PFS pre-filled syringe. The image depicts removing the red safety cap from the syringe and then placing the used syringe into a designated sharps container for safe disposal.*

FDA Label Image

Pfs Pouch 1 mg (Gvoke 20)

Gvoke PFS 1 mg per 0.2 mL (glucagon injection) pre-filled syringe label by Xeris Pharmaceuticals, Inc. The label includes step-by-step illustrations for preparing, injecting, and assisting during a low blood sugar emergency. It highlights injection sites on the body and components of the syringe, such as the needle cap, needle, viewing window, finger flange, and plunger.*

FDA Label Image

Pfs Image (Gvoke 21)

An illustration of a pre-filled syringe labeled with its parts including needle cap, needle, viewing window/syringe body, finger flange, and plunger. The diagram shows a side view to identify each component clearly.*

FDA Label Image

Ifub Slideb-f1 (Gvoke 22)

An instructional illustration showing hands preparing a Gvoke PFS pre-filled syringe. The first panel depicts peeling away a protective label or seal, and the second panel shows the syringe being removed from the packaging or protective case by pulling the syringe outward.*

FDA Label Image

Ifub Slideb-f2 (Gvoke 23)

Illustration showing a hand holding a pre-filled syringe labeled with an expiration date placeholder 'EXP: YYYY MM', highlighting the importance of checking the expiration date by looking at the syringe through a magnified eye graphic.*

FDA Label Image

Ifub Slideb-f3 (Gvoke 24)

Illustration showing instructions to visually inspect the Gvoke PFS 0.5 mg pre-filled syringe before use. The image depicts a hand holding the syringe and an eye looking closely at the medication chamber, indicating the step of checking the liquid inside the syringe.*

FDA Label Image

Ifub Slideb-f4 (Gvoke 25)

Illustration showing preferred injection sites on the human body for Gvoke PFS 0.5 mg pre-filled syringe. Front view highlights areas on the abdomen and thighs. Back view shows the upper outer arm as an injection site.*

FDA Label Image

Ifub Slideb-f5 (Gvoke 26)

An instructional illustration showing a person lifting their shirt and pulling their shorts or pants down slightly to expose the skin at the injection site for administering a medication.*

FDA Label Image

Ifub Slideb-f6 (Gvoke 27)

An instructional illustration showing a hand removing the needle cap from a pre-filled syringe. The text 'Pull Off Needle Cap' is displayed, indicating the step of preparing the syringe for injection by removing the protective cap from the needle.*

FDA Label Image

Ifub Slideb-f7 (Gvoke 28)

An instructional illustration showing two fingers pinching a fold of skin, labeled with the word 'Pinch' in a yellow box above the image. The image likely demonstrates a step in the administration process for the Gvoke PFS pre-filled syringe.*

FDA Label Image

Ifub Slideb-f8 (Gvoke 29)

An instructional illustration demonstrating the insertion of a Gvoke PFS pre-filled syringe needle at a 90-degree angle into the skin. The image shows a hand holding the syringe and another hand preparing the injection site.*

FDA Label Image

Ifub Slideb-f9 (Gvoke 30)

An instructional illustration showing a hand holding a pre-filled syringe labeled Gvoke PFS. The image demonstrates pushing the syringe needle into the skin for injection, with a downward arrow indicating the motion. The word 'Push' is displayed prominently at the top in a yellow bar.*

FDA Label Image

Ifub Slideb-f10 (Gvoke 31)

An instructional illustration depicting the use of a pre-filled syringe, showing one hand holding the syringe at an injection site on an arm, and an arrow pointing upward indicating removal of the syringe after injection.*

FDA Label Image

Ifub Slideb-f11 (Gvoke 32)

Illustration showing a person rolling onto their side from a lying position on their back. The sequence includes an arrow indicating the rolling motion, and the person ends lying on their side with one arm extended forward.*

FDA Label Image

Ifub Slideb-f12 (Gvoke 33)

An instructional illustration showing a hand disposing of a syringe into a red sharps container labeled 'SHARPS CONTAINER' with a biohazard symbol. The image depicts safe syringe disposal procedures.*

FDA Label Image

Full Vial And Syringe (Gvoke 34)

Illustration showing components of a Gvoke PFS 0.5 mg pre-filled syringe system. It includes a vial with blue cap, a syringe labeled with body, plunger, and needle, and a separate needle cap in red. The note states each vial and syringe should be used only once and then discarded.*

FDA Label Image

Gvoke Kit Figure A (Gvoke 35)

An instructional illustration showing a Gvoke PFS 0.5 mg pre-filled syringe with vial stopper and a separately packaged syringe needle cap or similar component, both positioned inside an open box. Arrows indicate these components are contained within the packaging.*

FDA Label Image

Gvoke Kit Figure B (Gvoke 36)

An instructional illustration showing a vial with a blue cap and an eye symbol. It highlights the expiration date location on the vial label with placeholder text 'EXP YYYY MM', indicating where to check the expiration date before use.*

FDA Label Image

Gvoke Kit Figure C (Gvoke 37)

An illustration depicting a vial with liquid medication and an eye above it, connected by dashed lines indicating a relationship or instruction between the eye and the vial contents. No text or specific dosage information visible.*

FDA Label Image

Gvoke Kit Figure D (Gvoke 38)

Illustration showing a hand holding a vial with a cap, demonstrating the removal of the cap by pulling it upward.*

FDA Label Image

Gvoke Kit Figure E (Gvoke 39)

Illustration showing a hand removing a cap by pulling it away from a pre-filled syringe, indicated by an arrow. The image demonstrates how to properly remove the syringe cap before injection, associated with Gvoke PFS 0.5 mg Pre-filled Syringe by Xeris Pharmaceuticals, Inc.*

FDA Label Image

Gvoke Kit Figure F (Gvoke 40)

An instructional illustration showing hands removing the red needle cap from a pre-filled syringe. The syringe is held in one hand pointing upward, and the other hand pulls the cap off as indicated by a black arrow. The image likely relates to the use of the Gvoke PFS 0.5 mg Pre-filled Syringe by Xeris Pharmaceuticals, Inc.*

FDA Label Image

Gvoke Kit Figure G (Gvoke 41)

An instructional illustration showing a hand holding a pre-filled syringe and inserting the needle into the rubber stopper of a vial. An arrow indicates a downward motion to puncture the stopper, demonstrating how to draw medication from the vial into the syringe.*

FDA Label Image

Gvoke Kit Figure H (Gvoke 42)

An instructional illustration showing how to properly hold and rotate a pre-filled syringe before use. The image depicts a hand gripping the syringe body and another hand rotating the cap or top part of the syringe in a clockwise direction.*

FDA Label Image

Gvoke Kit Figure I (Gvoke 43)

An instructional illustration showing a pre-filled syringe with volume markings labeled for dosing. The 0.1 mL mark is indicated for the pediatric dose, and the 0.2 mL mark is indicated for the adult dose, showing the syringe volume used for each dose.*

FDA Label Image

Gvoke Kit Figure J (Gvoke 44)

An anatomical illustration showing injection sites for Gvoke PFS 0.5 mg Pre-filled Syringe. Highlighted areas for injection include the lower abdomen, outer thigh, and outer upper arm, viewed from both front and back perspectives.*

FDA Label Image

Gvoke Kit Figure K (Gvoke 45)

Illustration showing guidance to expose the skin at the injection site for Gvoke PFS 0.5 mg Pre-filled Syringe. It depicts a person lifting their shirt to expose the abdomen and rolling up their pant leg to expose the thigh, indicating recommended injection locations.*

FDA Label Image

Gvoke Kit Figure L (Gvoke 46)

An instructional illustration showing a hand pinching the skin, likely preparing for an injection. The image is simple and uses muted colors to depict the technique of lifting the skin before administering a subcutaneous injection.*

FDA Label Image

Gvoke Kit Figure M (Gvoke 47)

Illustration showing the correct technique to hold a Gvoke PFS pre-filled syringe at a 90-degree angle for injection into the skin. The image depicts a hand holding the syringe perpendicular to a fingertip, demonstrating proper administration positioning.*

FDA Label Image

Gvoke Kit Figure N (Gvoke 48)

An instructional illustration showing a hand holding a pre-filled syringe vertically, with the needle pointing downward. Another hand is stabilizing the skin on an arm or abdomen, which is the injection site. A downward arrow indicates the direction to insert the syringe needle into the skin.*

FDA Label Image

Gvoke Kit Figure O (Gvoke 49)

An instructional illustration showing how to hold and pull a syringe upwards after injecting into the skin. The image depicts a hand gripping a syringe and another hand pinching the skin, with an arrow indicating the upward motion to remove the syringe.*

FDA Label Image

Gvoke Kit Figure P (Gvoke 50)

An instructional illustration showing a person lying on their side with their head tilted back to maintain an open airway, demonstrating positioning likely relevant to the use of Gvoke PFS 0.5 mg pre-filled syringe for emergency treatment.*

FDA Label Image

Gvoke Kit Figure Q (Gvoke 51)

Illustration showing a hand disposing of a used syringe into a labeled sharps container, demonstrating proper sharps disposal technique for medical safety.*

FDA Label Image

Ai 1mg Device Label (Gvoke 52)

Gvoke HypoPen 1 mg per 0.2 mL (glucagon injection) pre-filled syringe label. It specifies use for subcutaneous injection with a single-dose auto-injector. The label includes distribution details for Xeris Pharmaceuticals, Inc., Chicago, IL. Needle end is indicated on the design.*

FDA Label Image

Ai 1 mg Pouch Label (Gvoke 53)

Gvoke HypoPen glucagon injection label showing 1 mg per 0.2 mL strength. The label indicates it is a single-dose auto-injector for subcutaneous use. It is distributed by Xeris Pharmaceuticals, Inc. The front side highlights storage instructions, usage warnings, and a barcode. The back side provides step-by-step pictorial instructions for preparation, injection, and post-injection care, emphasizing use for low blood sugar emergency.*

FDA Label Image

Ai 1 mg 1-pack Carton Label (Gvoke 54)

Gvoke HypoPen 1 mg per 0.2 mL (glucagon injection) single-dose auto-injector carton from Xeris Pharmaceuticals. The label highlights use for low blood sugar emergency and includes detailed use instructions with illustrations showing preparation, injection, and assistance steps. The label also displays storage instructions, safety warnings, and product vial image with red cap and needle end marked.*

FDA Label Image

Ai 1mg 2-pack Carton Label (Gvoke 55)

Packaging label for Gvoke HypoPen (glucagon injection) 1 mg per 0.2 mL single-dose auto-injector by Xeris Pharmaceuticals, Inc. The label indicates it is for low blood sugar emergency and contains two single-dose auto-injectors. Instructions for use and storage conditions are shown, along with a depiction of the auto-injector device with a red cap.*

FDA Label Image

Ai-0.5-mg-device-label (Gvoke 56)

Label of Gvoke HypoPen glucagon injection with a strength of 0.5 mg per 0.1 mL. It is indicated for subcutaneous use only and is a single-dose auto-injector. The label lists Xeris Pharmaceuticals, Inc. as the distributor, located in Chicago, IL.*

FDA Label Image

Ai-0.5-mg-pouch-label (Gvoke 57)

Gvoke HypoPen 0.5 mg per 0.1 mL pre-filled syringe labels, glucagon injection by Xeris Pharmaceuticals, Inc. The label states it is for low blood sugar emergencies and includes usage instructions for subcutaneous injection. The label features dosage information, storage instructions, and contact details for the manufacturer.*

FDA Label Image

Ai-0.5-mg-1-pack-carton-label (Gvoke 58)

Packaging label for Gvoke HypoPen glucagon injection 0.5 mg per 0.1 mL single-dose auto-injector by Xeris Pharmaceuticals, Inc. The label highlights its use for low blood sugar emergency and contains one pre-filled syringe. Instructions for preparation, injection, and assistance are illustrated on the label. Storage and usage warnings are also present.*

FDA Label Image

Ai0.5-mg-1-pack-carton-label (Gvoke 59)

Gvoke HypoPen 0.5 mg per 0.1 mL (glucagon injection) single-dose auto-injector packaging label by Xeris Pharmaceuticals. The label shows dosage strength, injection instructions, storage information, and the product is intended for low blood sugar emergency with 2 single-dose auto-injectors included.*

FDA Label Image

Pfs 1 mg Device Label (Gvoke 60)

Label for Gvoke PFS (glucagon injection) 1 mg per 0.2 mL pre-filled syringe. Packaging states it is for subcutaneous use only, single-dose. Distributed by Xeris Pharmaceuticals, Inc., Chicago, IL. Lot number and expiration date fields are blank placeholders.*

FDA Label Image

Pfs 1mg Pouch Label (Gvoke 61)

Gvoke PFS 1 mg per 0.2 mL pre-filled syringe glucagon injection label from Xeris Pharmaceuticals, Inc. The front label states use for low blood sugar emergency and includes storage instructions. A separate instructional label illustrates steps to prepare, inject, and assist after injection using the syringe.*

FDA Label Image

Pfs 1mg 1-pack Carton Label (Gvoke 62)

Gvoke PFS 1 mg per 0.2 mL pre-filled syringe packaging label featuring glucagon injection for low blood sugar emergency. The label shows the syringe image, dosing strength, and instructions for subcutaneous use. Manufactured by Xeris Pharmaceuticals, Inc., it includes preparation, injection, and assistance steps with diagrams.*

FDA Label Image

Pf 1mg 2-pack Carton Label (Gvoke 63)

Gvoke PFS 1 mg per 0.2 mL pre-filled syringe carton label by Xeris Pharmaceuticals, Inc. The label indicates it contains 2 single-dose syringes for glucagon injection used for low blood sugar emergency. It includes instructions for subcutaneous use and storage guidelines. The packaging displays an image of the syringe and detailed injection instructions.*

FDA Label Image

Kit Vial Label (Gvoke 64)

Label for Gvoke Kit (glucagon injection) showing 1 mg per 0.2 mL strength. It is a single-dose vial intended for subcutaneous use; unused portion should be discarded. The label includes storage instructions, manufacturer Xeris Pharmaceuticals, Inc., and placeholders for lot number and expiration date.*

FDA Label Image

Kit Pouch Label (Gvoke 65)

Gvoke PFS 0.5 mg Pre-filled Syringe packaging label containing usage instructions and storage information. It specifies one single-dose sterile syringe with a 29 gauge 1/2 inch needle, marked for 0.1 mL and 0.2 mL, for subcutaneous use only. The label advises using with Gvoke vial only, non-reuse, and not making with natural rubber latex. Distributed by Xeris Pharmaceuticals, Inc., Chicago, IL.*

FDA Label Image

Kit Carton Label Side 1 (Gvoke 66)

Gvoke Kit glucagon injection 1 mg per 0.2 mL single-dose vial and syringe packaging label by Xeris Pharmaceuticals, Inc. The label specifies it is for low blood sugar emergency and includes a single-dose vial containing glucagon injection with a disposable syringe. The label features dosing instructions and storage information, with a space marked for the pharmacy patient label.*

FDA Label Image

Kit Carton Label Side 2 (Gvoke 67)

Quick Guide Instructions for Gvoke Kit 1 mg per 0.2 mL glucagon injection. The fold-out cardboard displays step-by-step illustrated instructions for preparing, drawing dose, injecting, assisting, and disposing of the glucagon syringe vial kit. Panels include instructions for flipping blue vial caps, needle insertion, dosage drawing (0.1 mL pediatric, 0.2 mL adult), preferred injection sites shown on body diagrams, and proper disposal advice.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.